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Editorial Note: The gender initiative
continues with editorials addressing
noncardiac vascular surgery: (1) Ex-
perts discuss sex-based differences in
the prevalence of vascular disease; (2)
the pathophysiology, risks, and benefits
of surgical treatment of carotid disease
in women; (3) the need for clarifying
optimal timing for surgical repair of ab-
dominal aortic aneurysms in women
and for refining endovascular repair
technology for small patients; and (4)
current outcomes (limb salvage, graft
patency, and mortality) and future re-
search in women with peripheral arte-
rial occlusive disease. The series con-
tinues next month with editorials on
end-stage heart failure.
Nancy A. Nussmeier, MD
Texas Heart Institute
See related editorials on pages 318, 322,
and 325.
Knowledge of the clinical consequences of atherosclerosis andcardiovascular disease has grown tremendously over the years.Most persons, patients and physicians alike, understand and ac-cept the critical importance of heart disease, yet the significanceof noncardiac vascular disease remains largely underappreciated.The 3 major areas of noncardiac vascular disease include carotid
artery occlusive disease, aortic aneurysmal disease, and peripheral arterial occlusive
disease (PAD). These diseases, with their associated risks of stroke, limb loss, and
death, are often undiagnosed and untreated despite being common causes of death
and loss of function in the United States. Although previous studies have reported
that the prevalence of vascular disease is greater in men than in women, that gap
closes quickly with increasing age. As the American population ages, the prevalence
of noncardiac vascular disease in women will increase, making it a leading cause of
mortality and morbidity for women. The importance of disease prevention and
detection of noncardiac vascular disease in women cannot be overlooked. To date,
few studies have focused on the prevalence and importance of vascular disease in
women.
Carotid Artery Occlusive Disease
Stroke is the third leading cause of death in the United States and a leading cause
of permanent disability among older Americans. Nearly $70 billion is estimated to
be spent each year on the care of stroke survivors.1 Most strokes are ischemic, and
most ischemic strokes are caused by cerebrovascular disease. According to the
Atherosclerosis Risk in Communities Study from the American Heart Association,
approximately 83% of strokes are ischemic (thromboembolic), whereas 17% are
hemorrhagic. The risk of stroke is reported to be 1.5 times greater in men than in
women of the same age. The natural history of the patients experiencing a stroke
suggests that only 50% will be alive at 5 years, with 38% dying from the initial
stroke. Of those who survive the initial event, only 30% will function normally, and
up to 5% will require custodial care. Any patient with symptoms of cerebrovascular
disease should be managed aggressively because the sequelae of a stroke can be
devastating. However, only 30% to 50% of patients have any symptoms before a
stroke, and therefore the importance of detecting cerebral vascular disease cannot be
overemphasized.
The benefit of carotid endarterectomy for both symptomatic and asymptomatic
carotid artery stenosis has been well studied. However, those studies that examined
the role of carotid endarterectomy for occlusive disease included a low percentage
of women.2,3 Men comprise the majority of patients recruited for the major clinical
trials on asymptomatic and symptomatic carotid disease. (Asymptomatic Carotid
Atherosclerosis Study: 67% were men, and 33% were women; North American
Symptomatic Carotid Endarterectomy Trial: 71% were men, and 30% were women;
the Veterans Affairs cooperative study enrolled no women).4-7 A study that specif-
ically reviewed the sex differences in carotid endarterectomy outcomes from On-
tario, Canada, reported that only 35% of the 6038 patients in their registry were
women.8 Consequently, conclusions have been drawn on the potential benefits of
carotid surgery for women. These studies, however, might not necessarily reflect the
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true incidence of the disease in women, and a clear under-
standing of cerebrovascular disease in women is clouded by
a scarcity of studies with an adequate number of women.
Aortic Aneurysmal Disease
Abdominal aortic aneurysms (AAAs) account for at least
15,000 deaths per year in the United States. This figure
might even be a gross underestimate because many patients
with ruptured aneurysms are not given a diagnosis before
their rupture, and furthermore, a number of these patients
might not even make it to the hospital.9,10 Most surgical
series suggest that AAAs are primarily a disease of elderly
men, with the number of affected men outnumbering wom-
en.11-13 Age-adjusted incidence for both asymptomatic and
ruptured AAAs is 4 to 6 times higher in men compared with
that in women.14,15 This risk of AAA increases with age,
and the difference in prevalence between men and women
closes in the eighth decade of life.
Although most patients with AAAs are asymptomatic
and often are given a diagnosis during routine physical
examination or evaluation for other disease processes, the
mortality rate for those symptomatic can be as high as 90%.
Rupture from AAA constitutes the 10th leading cause of
death among men older than 55 years of age. When aneu-
rysms are diagnosed early, they can be treated safely, with
a mortality rate of 5% or less.16-19 Currently, many AAAs
can be treated by using less-invasive techniques that avoid
the need for major surgical procedures. However, when
AAAs progress to rupture, they are fatal in more than half
the cases. AAAs can be diagnosed easily in minutes without
risk or discomfort by using duplex ultrasound scanning.20-22
AAA and its pathogenesis remain a central concern in the
study of vascular disease because of the incidence and
catastrophic consequences of rupture.
As the population ages and the gap in prevalence of
AAAs between men and women narrows, it will become
increasingly important to determine specific risks that might
affect women. Women are often given a diagnosis at a later
age and are offered elective repair at a significantly lower
rate than men.23,24 In addition, AAAs diagnosed in women
are more likely to be ruptured at the time of diagnosis
than is the case among men.25 Women also are less likely
candidates for current less-invasive techniques of repair,
often because of anatomic limitations. Perhaps sex dif-
ferences in outcomes of diagnostic and therapeutic pro-
cedures influence physicians’ patterns in referring
women for treatment.
Peripheral Arterial Occlusive Disease
PAD affects 8 to 12 million Americans. The estimate is that
nearly 20% of persons older than 70 years of age have PAD.
PAD is associated with a 5-fold to 6-fold increased risk of
cardiovascular morbidity and death.26,27 Intermittent clau-
dication is the classic manifestation and is associated with
impaired lifestyle and lower extremity functioning. Patients
also might have limb-threatening ischemia. The ankle-bra-
chial index (ratio of the systolic blood pressure in the ankle
to that in the arm) is a reliable, simple, and objective
measurement used to assess PAD.28-30 Many patients are
not given a diagnosis of PAD until they have symptoms of
intermittent claudication.31 It has been well documented
that development of mild-to-moderate intermittent claudi-
cation poses a low threat of limb loss, with up to 75% of
patients stabilizing or improving, whereas only 5% to 7%
eventually require amputation. The effect of amputation can
be devastating, with an overall survival rate of 50% or less
at 10 years compared with 90% at 5 years in age-adjusted
control subjects. Many patients with claudication, however,
do not complain of symptoms and often accept difficulty in
walking as part of the normal aging process.
Previous studies have shown that women are less likely
to be given a diagnosis on the basis of symptoms but do
have clinically significant PAD when tested.32,33 The tradi-
tional belief that the prevalence of PAD is greater in men
than in women does not take into account that women might
have more asymptomatic disease. Symptomatic PAD so
predominates in men that many reports of surgical therapy
do not investigate sex-specific outcomes.34 Moreover, stud-
ies have shown that infrainguinal arterial reconstructions
performed on women tend to be for more advanced disease
compared with those in their male counterparts, and the
women tend to be older.35,36 In addition, experience at the
University of Maryland over the past 5 years disclosed that
more than 50% of women who have PAD are seen initially
with such advanced limb-threatening ischemia that they
undergo primary amputation without the opportunity for
revascularization (unpublished data). We speculate that
some of the reasons women might be given diagnoses at a
more advanced stage of ischemia are (1) that women might
focus more on seeking medical care for their families than
for themselves, (2) that women are more likely to ignore
mild-to-moderate symptoms (attributing symptoms to “old
age”) and therefore present with more advanced occlusive
disease, and (3) economic considerations. Without correct-
ing for the more advanced presentation, women might ap-
pear to have worse outcomes as a group.
The American Vascular Association National
Screening Program
Accurate incidence estimates for carotid artery disease, pe-
ripheral arterial disease, and aneurysmal disease have not
been available because nationwide screening surveys of the
population were not conducted until 2002. The American
Vascular Association (AVA) then performed its first Na-
tional Screening Program for carotid disease, AAA, and
PAD in older Americans at high risk for atherosclerosis. In
its first year, more than 850 persons were tested at 17
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centers across the nation. The mean patient age was 65
years. More than 60% of those who presented for screening
were women, and more than 13% of those tested had
abnormal examinations. This screening was expanded to 48
centers in 2003, during which a total of 1587 persons were
screened. Again more than 60% of those screened were
women. The mean patient age was 68 years. These 2 screen-
ings combined totaled 2446 persons (1479 women and 967
men).
Through the AVA screening, carotid artery stenosis (in-
ternal carotid artery stenosis 50%) was observed in ap-
proximately 8% of the population screened. An additional
2% were found to have severe carotid artery disease (80%-
99%). Thus clinically relevant carotid artery disease was
found in approximately 9% of the persons screened. Over-
all, carotid artery stenosis was significantly more likely in
men (8%) than in women (6%, P  .03). Less than half
(47%) of the persons determined to have more than 50%
internal carotid artery stenosis were receiving antiplatelet
medications (aspirin, clopidogrel, or ticlopidine) that might
reduce their risk of stroke. Among those with 80% to 99%
internal carotid artery stenosis, nearly one third (29%) were
not receiving antiplatelet treatment. Interestingly, of those
patients with carotid artery stenosis, men were more likely
than women to be taking antiplatelet medications (58% vs
32%, P  .0006).
AAAs (aortic diameter3.0 cm) were observed in 2% of
the population screened; approximately 11% were more than
5.0 cm in diameter, and none of these had been diagnosed
previously. Of the total persons in both screenings combined
with an aorta of greater than 3.0 cm, 2% were women, and 4%
were men. Although more AAAs were detected in men than in
women during this screening, the ratio of men to women was
not as disparate as traditionally reported.
PAD (ankle-brachial index 0.85) was observed in 9%
of the population screened, 11% of men and 8% of women
(P  .001). Among those observed to have PAD at the time
of screening, less than half (47%) were not receiving med-
ical treatments (eg, antiplatelet or lipid-lowering agents)
that might reduce the risk of myocardial infarction and
stroke (known incidence to be 2-3 times more common in
those with PAD). As with carotid disease, men were more
likely to be taking antiplatelet medications than women
(58% vs 40%, P .0067). Moreover, men were more likely
(87%) than women (63%) to be receiving lipid-lowering
medications (P  .0062).
Overall, this national screening program confirms that
vascular disease is underdiagnosed and undertreated in a
broad segment of the US population. Similarly, a regional
screening program of 8476 persons in New England re-
ported a high prevalence (37%) of previously undiagnosed
peripheral vascular disease. Peripheral vascular disease was
identified on the basis of either an ankle-brachial index of
less than 0.90, carotid artery stenosis of more than 15%, or
AAA of greater than 3 cm in the population tested. As in the
AVA national screening program, 67% of the population
screened were women with a mean age of 65 years.37 These
screenings showed that although men were more likely to
have carotid artery stenosis, PAD, and aneurysmal disease,
the ratios are not as disparate as touted previously. Over the
next 5 years, this annual AVA screening program will
continue to expand, with a goal of greater than 5000 patients
screened. The data collected will become the most compre-
hensive collection of information regarding the prevalence
of vascular disease assembled.
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